| Identification | Back Directory | [Name]
4-((3-bromophenyl)sulfonyl)-N-(1-(thiophen-2-yl)ethyl)piperazine-1-carboxamide | [CAS]
1090528-71-4 | [Synonyms]
T6167923
(Rac)-T6167923
1-Piperazinecarboxamide, 4-[(3-bromophenyl)sulfonyl]-N-[1-(2-thienyl)ethyl]-
4-((3-bromophenyl)sulfonyl)-N-(1-(thiophen-2-yl)ethyl)piperazine-1-carboxamide
T6167923 4-(3-Bromophenyl)sulfonyl-N-(1-thiophen-2-
ylethyl)piperazine-1-carboxamide | [Molecular Formula]
C17H20BrN3O3S2 | [MDL Number]
MFCD10674208 | [MOL File]
1090528-71-4.mol | [Molecular Weight]
458.39 |
| Chemical Properties | Back Directory | [Melting point ]
162-165°C | [storage temp. ]
-20°C Freezer | [solubility ]
DMSO (Slightly), Methanol (Slightly, Heated, Sonicated) | [form ]
Solid | [color ]
White to Off-White |
| Hazard Information | Back Directory | [Uses]
T6167923 is a novel inhibitor of MyD88-dependent signaling pathways, disrupting MyD88 homodimeric formation, which is critical for its signaling function |
|
| Company Name: |
cjbscvictory
|
| Telephone: |
13348960310 13348960310 |
| Website: |
www.weikeqi-biotech.com/ |
|